D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Red Robin
RRGB
$139M
| $665K | ﹤0.01% |
21,746
+3,839
| +21% | +$118K |
|
|
UNIT
2877
PUT
Uniti Group
UNIT
$2.62B
| $665K | ﹤0.01% |
70,000
| – | – |
|
2878
Powell Industries
POWL
$8.32B
| $662K | ﹤0.01% |
52,254
-14,628
| -22% | -$163K |
|
2879
PUT
Synchrony
SYF
$24.3B
| $662K | ﹤0.01% |
+19,100
| New | +$647K |
|
2880
PUT
Theravance Biopharma
TBPH
$875M
| $661K | ﹤0.01% |
+40,500
| New | +$821K |
|
|
PENG
2881
Penguin Solutions Inc
PENG
$2.75B
| $661K | ﹤0.01% |
+57,488
| New | +$581K |
|
|
JNCE
2882
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $660K | ﹤0.01% |
133,443
-40,365
| -23% | -$214K |
|
2883
Franklin Resources
BEN
$17.4B
| $659K | ﹤0.01% |
+18,947
| New | +$644K |
|
2884
Dime Commercial Bancshares
DCOM
$1.76B
| $659K | ﹤0.01% |
22,349
-7,493
| -25% | -$222K |
|
2885
CALL
Aflac
AFL
$64.1B
| $658K | ﹤0.01% |
+12,000
| New | +$619K |
|
2886
BBVA Argentina
BBAR
$3.93B
| $657K | ﹤0.01% |
57,997
-152,076
| -72% | -$1.42M |
|
|
PBCT
2887
DELISTED
People's United Financial Inc
PBCT
| $657K | ﹤0.01% |
+39,129
| New | +$650K |
|
2888
PUT
National Health Investors
NHI
$3.85B
| $655K | ﹤0.01% |
8,400
-800
| -9% | -$62.2K |
|
|
ARR
2889
Armour Residential REIT
ARR
$2.03B
| $654K | ﹤0.01% |
+7,024
| New | +$660K |
|
2890
Rigel Pharmaceuticals
RIGL
$713M
| $654K | ﹤0.01% |
25,056
+15,953
| +175% | +$360K |
|
2891
Sabra Healthcare REIT
SBRA
$5.61B
| $654K | ﹤0.01% |
33,222
-99,627
| -75% | -$1.94M |
|
|
LTS
2892
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $654K | ﹤0.01% |
190,683
+1,171
| +0.6% | +$4.05K |
|
2893
WaFd
WAFD
$2.71B
| $653K | ﹤0.01% |
18,700
-35,010
| -65% | -$1.13M |
|
2894
PUT
Fastenal
FAST
$54.3B
| $652K | ﹤0.01% |
40,000
| – | – |
|
2895
Merchants Bancorp
MBIN
$2.22B
| $652K | ﹤0.01% |
57,456
-4,776
| -8% | -$65.5K |
|
2896
CALL
Zillow
Z
$7.23B
| $649K | ﹤0.01% |
+14,000
| New | +$558K |
|
2897
PUT
Zebra Technologies
ZBRA
$12.7B
| $649K | ﹤0.01% |
3,100
-8,900
| -74% | -$1.79M |
|
|
ALDR
2898
DELISTED
Alder Biopharmaceuticals
ALDR
| $647K | ﹤0.01% |
+54,912
| New | +$665K |
|
2899
Biglari Holdings Class A
BH.A
$1.19B
| $646K | ﹤0.01% |
1,218
| – | – |
|
2900
MeiraGTx Holdings
MGTX
$1.18B
| $644K | ﹤0.01% |
23,947
+9,341
| +64% | +$193K |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.